FDA adds boxed warning to Teva's Copaxone and generic versions after serious allergic reactions, including anaphylaxis that ...

Anthos Therapeutics' abelacimab shows lower bleeding risk vs Xarelto in atrial fibrillation trial, with 62% reduction in ...

We’re in the first week of the second Trump administration, and it’s becoming clearer how it might impact healthcare ...

UnitedHealth Group has named a new CEO to lead its health insurance business, following the murder of the division’s former top executive in December.

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement in a longstanding legal battle over the nation’s opioid epidemic.

Teva, Astellas and AstraZeneca say they will participate in the next round of Medicare negotiations under the Inflation Reduction Act, even though they continue to criticize the process as “price ...

FDA delays Stealth BioTherapeutics' elamipretide decision to April 29; Valneva's Ixchiq succeeds in child safety trial; TargetRx raises $50M; Ab&B Bio-Tech files for HKEX IPO ...

Catalent to make Galapagos' CAR-T therapy, Kindeva gets $129M DuoDote contract, Solarbiotech/GPC Bio/Eleszto merge, Afrigen ...

Quantum Health laid off 4% of workforce shortly after naming Dayne Williams as CEO. The company serves 3M+ members for ...

Just over 20 years ago, the people of California voted to spend billions of dollars on an exciting new idea to remake ...

J&J's depression drug Spravato hits $1B in 2024 sales, up 56% from 2023, with expanded label approval and 140,000+ patients ...

Xilio's vilastobart plus Roche's Tecentriq shows partial responses in colorectal cancer trial, but company faces cash ...